AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0086
-0.0001 (-1.15%)
Jun 20, 2024, 11:14 AM EDT - Market open

AXIM Biotechnologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2011
Cash & Equivalents
0.160.050.450.460.51
Upgrade
Short-Term Investments
00000.24
Upgrade
Cash & Cash Equivalents
0.160.050.450.460.75
Upgrade
Cash Growth
230.90%-89.56%-0.92%-39.27%-61.50%
Upgrade
Receivables
00000.32
Upgrade
Inventory
00000.49
Upgrade
Other Current Assets
00.060.180.260.08
Upgrade
Total Current Assets
0.160.10.640.711.64
Upgrade
Property, Plant & Equipment
0.360.110.190.230
Upgrade
Long-Term Investments
0.020.050.10.10
Upgrade
Goodwill
0002.460
Upgrade
Intangible Assets
3.593.994.387.80.05
Upgrade
Other Long-Term Assets
0.01-0.040.010.010
Upgrade
Total Long-Term Assets
3.994.114.6910.60.05
Upgrade
Total Assets
4.154.215.3211.311.69
Upgrade
Accounts Payable
2.781.320.911.070.77
Upgrade
Deferred Revenue
0.30.33000
Upgrade
Current Debt
0.090.021.640.41.05
Upgrade
Other Current Liabilities
2.81.720.030.031.57
Upgrade
Total Current Liabilities
5.983.392.581.53.4
Upgrade
Long-Term Debt
5.435.645.085.915.06
Upgrade
Other Long-Term Liabilities
0.37002.340
Upgrade
Total Long-Term Liabilities
5.85.645.088.255.06
Upgrade
Total Liabilities
11.789.047.669.758.45
Upgrade
Total Debt
5.665.666.726.316.1
Upgrade
Debt Growth
-0.11%-15.69%6.49%3.38%4.02%
Upgrade
Common Stock
0.020.020.010.010.01
Upgrade
Retained Earnings
-72.18-64.13-57.88-41.85-35.44
Upgrade
Comprehensive Income
-00.144.530.20.05
Upgrade
Shareholders' Equity
-7.63-4.83-2.341.57-6.76
Upgrade
Total Liabilities and Equity
4.154.215.3211.311.69
Upgrade
Net Cash / Debt
-5.5-5.62-6.27-5.85-5.35
Upgrade
Net Cash Per Share
-0.02-0.03-0.05-0.05-0.09
Upgrade
Working Capital
-5.82-3.29-1.94-0.78-1.76
Upgrade
Book Value Per Share
-0.03-0.03-0.020.01-0.11
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.